Bladder Cancer - Results from #20

Utility of lymphadenectomy in bladder cancer: where do we stand? March 30, 2020

Transurethral resection of bladder tumor and the need for re-transurethral resection of bladder tumor: time to change our practice? March 30, 2020

The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor. March 30, 2020

The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC). March 30, 2020

Dietary inflammatory index and bladder cancer risk: a prospective study. March 30, 2020

Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis. March 30, 2020

Supply and Clinical Application of Actinium-225 and Bismuth-213. March 27, 2020

Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper. March 27, 2020

Comparing Provider-Led Sexual Health Counseling of Male and Female Patients Undergoing Radical Cystectomy. March 27, 2020

Infinity Receives Fast Track Designation for IPI-549 in Combination with the Checkpoint Inhibitor Opdivo for the Treatment of Advanced Urothelial Cancer March 26, 2020

Smoke load prognostic impact on bacillus Calmette-Guérin (BCG) treated non-muscle invasive bladder cancer. March 26, 2020

Programmed death-ligand 2 (PD-L2) expression in bladder cancer. March 26, 2020

ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes. March 26, 2020

Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers. March 26, 2020

Genomic Subtyping in Bladder Cancer. March 25, 2020

Evaluation of Autofluorescence and Photodynamic Diagnosis in Assessment of Bladder Lesions. March 25, 2020

Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. March 25, 2020

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer. March 25, 2020

Targets for Therapy of Bladder Cancer. March 24, 2020

Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography? March 24, 2020

Page 2 of 337